REQUEST A DEMO
Total
USD $0.00
Search more companies

Lily Pharma Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lily Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lily Pharma Company Limited is a company based in Thailand, with its head office in Bangkok , Special Governed District of. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on June 01, 2026. It currently has a total number of 40 (estimated) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 476.71% in 2024. Its’ total assets recorded a growth of 54.68%.

Headquarters
1 Soi Ramindra 21 Yaek 20, Ramindra Raod
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10220

Contact Details: Purchase the Lily Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Lily Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Lily Pharma Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Proprietor
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Lily Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
476.71%
Total Operating Revenue
461.53%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
54.68%
Total Equity
7.24%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
47.61%
Quick Ratio
1.26%
Cash Ratio
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?